News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
753,696 Results
Type
Article (57356)
Company Profile (700)
Press Release (695640)
Section
Business (216830)
Career Advice (2797)
Deals (37413)
Drug Delivery (115)
Drug Development (86455)
Employer Resources (179)
FDA (17582)
Job Trends (15955)
News (369742)
Policy (36945)
Tag
Academia (2907)
Alliances (53355)
Alzheimer's disease (1357)
Approvals (17526)
Artificial intelligence (168)
Bankruptcy (380)
Best Places to Work (12372)
Biotechnology (491)
Breast cancer (201)
Cancer (1476)
Cardiovascular disease (125)
Career advice (2344)
Cell therapy (317)
Clinical research (68805)
Collaboration (531)
Compensation (280)
COVID-19 (2798)
C-suite (121)
Data (1435)
Diabetes (194)
Diagnostics (6608)
Earnings (88491)
Employer resources (157)
Events (118234)
Executive appointments (419)
FDA (18316)
Funding (469)
Gene therapy (223)
GLP-1 (694)
Government (4873)
Healthcare (20285)
Infectious disease (2900)
Inflammatory bowel disease (124)
Interviews (493)
IPO (17149)
Job creations (4057)
Job search strategy (1970)
Layoffs (476)
Legal (9109)
Lung cancer (217)
Manufacturing (232)
Medical device (14202)
Medtech (14207)
Mergers & acquisitions (20438)
Metabolic disorders (523)
Neuroscience (1715)
NextGen Class of 2024 (7353)
Non-profit (4954)
Northern California (1760)
Obesity (300)
Opinion (233)
Patents (130)
People (60020)
Pharmaceutical (136)
Phase I (21429)
Phase II (30089)
Phase III (22531)
Pipeline (532)
Postmarket research (3001)
Preclinical (9289)
Radiopharmaceuticals (257)
Rare diseases (295)
Real estate (6465)
Regulatory (24568)
Research institute (2597)
Resumes & cover letters (463)
Southern California (1527)
Startups (3949)
United States (16423)
Vaccines (659)
Weight loss (228)
Date
Last 7 days (190)
Last 30 days (1727)
Last 365 days (36883)
2025 (109)
2024 (37657)
2023 (42141)
2022 (53493)
2021 (58266)
2020 (57078)
2019 (50276)
2018 (38196)
2017 (35213)
2016 (35181)
2015 (41107)
2014 (34981)
2013 (30229)
2012 (32390)
2011 (32900)
2010 (31039)
Location
Africa (938)
Arizona (217)
Asia (42889)
Australia (7303)
California (4087)
Canada (1496)
China (341)
Colorado (184)
Connecticut (205)
Europe (96027)
Florida (561)
Georgia (146)
Illinois (436)
Indiana (243)
Maryland (694)
Massachusetts (3242)
Michigan (184)
Minnesota (315)
New Jersey (1178)
New York (1144)
North Carolina (864)
Northern California (1760)
Ohio (156)
Pennsylvania (970)
South America (1329)
Southern California (1527)
Texas (600)
Utah (114)
Washington State (443)
753,696 Results for "helsinn therapeutics us inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US
Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, is pleased to announce that AKYNZEO® (fosnetupitant/palonosetron) injection is now available in the US in a ready-to-use vial.
June 24, 2024
·
5 min read
Press Releases
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors
September 20, 2024
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Pharm Country
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM.
April 23, 2024
·
7 min read
Press Releases
Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market
December 23, 2024
·
5 min read
Helsinn closes financing agreement with BancaStato to support business objectives and growth
Helsinn Group announces the signing of a new financing agreement with BancaStato, effective from September 2023.
October 10, 2023
·
3 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression
December 30, 2024
·
6 min read
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
In the U.S., the chorus of opposition against the proposed buyout continues to grow and now includes the CEOs of Roche and Lilly, a broad coalition of unions and consumer groups and at least one senator.
December 9, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Open Healthcare Inc. Expands U.S. Operations With CTON Laboratory Acquisition, New Facility in Gardena, and Appointment of New COO
December 23, 2024
·
3 min read
Press Releases
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality
December 19, 2024
·
5 min read
1 of 75,370
Next
